trending Market Intelligence /marketintelligence/en/news-insights/trending/WBMMnIfnxI53YGhF9PU0Eg2 content esgSubNav
In This List

Invictus scraps Nasdaq listing plans

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


Invictus scraps Nasdaq listing plans

White Rock, British Columbia-based Invictus MD Strategies Corp. has dropped plans to list on the Nasdaq Capital Market, and a connected share consolidation.

The company applied to list its common shares on the market in January 2019.

"The intended timing of a Nasdaq uplist was premature and underway prior to my assumption of responsibilities," said CEO George Kveton, noting that the cannabis company is committed to bring its purpose-built indoor cultivation facilities into production.

The company's board expects to revisit the Nasdaq listing plan in the future.

Invictus will continue to trade on the TSX Venture Exchange under the ticker GENE, on the OTCQB Venture Market under the symbol IVITF, and on the Frankfurt Stock Exchange under the ticker 8IS2.